We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.

UREA CYCLE DISORDER TREATMENT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2020 - 2027)

Urea Cycle Disorder Treatment Market, by Treatment Type (Amino Acid Supplements, Sodium Phenylbutyrate, Glycerol Phenylbutyrate, Sodium Benzoate, and Others (Low Protein Diet, Carglumic acid, etc.), By Enzyme Deficiency Type (OTC – Ornithine Transcarbamylase, AS – Argininosuccinate Synthetase (citrullinemia), AG – Arginase, AL – Argininosuccinate Lyase, CPS1 – Carbamoyl Phosphate Synthase, and NAGS – N-acetylglutamate Synthase), By Route of Administration (Oral and Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Published In: 24 May, 2021
Code: CMI4441
Page number: 272
Formats: Excel and PDF
Industry: Pharmaceutical

Table of Contents (Version-2026)

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Treatment Type
  - Market Snapshot, By Enzyme Deficiency Type
  - Market Snapshot, By Route of Administration
  - Market Snapshot, By Distribution Channel
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Key Developments
- Treatment Approaches
- Novel Therapies Under Development for the Treatment of UCD
- Mergers, Collaborations, Acquisitions & Agreements
- Pipeline Analysis
- Regulatory Scenario
- PEST Analysis
- Product Approvals
- Market Trends
- Epidemiology
- Therapeutics Overview
- Brand Analysis
- Reimbursement Scenario
- Prescription Overview
Global
Urea Cycle Disorders Treatment
Market, Impact of COVID-19 Pandemic
- COVID-19 Impact on Overall Healthcare Sector
- COVID-19 Epidemiology
- Impact of COVID-19 Impact on Supply Chain
- Covid-19 Impact on Clinical Trials and Drug Development
Global
Urea Cycle Disorders Treatment
Market, By Treatment Type, 2016-2027 (US$ Mn)
- Introduction
  - Market Share Analysis, 2020 and 2027 (%)
  - Y-o-Y Growth Analysis, 2017–2027
  - Segment Trends
    - Amino Acid Supplements
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
    - Sodium Phenylbutyrate
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
    - Glycerol Phenylbutyrate
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
    - Sodium Benzoate
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
    - Others (Low Protein Diet, Carglumic acid, etc.)
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
Global
Urea Cycle Disorders Treatment
Market, By Enzyme Deficiency Type, 2016-2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017–2027
- Segment Trends
  - - OTC – Ornithine Transcarbamylase
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
    - AS – Argininosuccinate Synthetase (citrullinemia)
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
    - AG – Arginase
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
    - AL – Argininosuccinate Lyase
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
    - CPS1 – Carbamoyl Phosphate Synthase
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
    - NAGS – N-acetylglutamate Synthase
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
Global
Urea Cycle Disorders Treatment
Market, By

Route of Administration
, 2016–2027 (US$ Mn)
- Introduction
  - Market Share Analysis, 2020 and 2027 (%)
  - Y-o-Y Growth Analysis, 2017–2027
  - Segment Trends
    - Oral
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
    - Injectable
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
Global
Urea Cycle Disorders Treatment
Market, By

Distribution Channel
, 2016–2027 (US$ Mn)
- Introduction
  - Market Share Analysis, 2020 and 2027 (%)
  - Y-o-Y Growth Analysis, 2017–2027
  - Segment Trends
    - Hospital Pharmacies
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
    - Retail Pharmacies
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
    - Online Pharmacies
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
Global
Urea Cycle Disorders Treatment
Market, By Region, 2016–2027 (US$ Mn)
- Introduction
  - Market Share Analysis, By Country, 2020 and 2027 (%)
  - Y-o-Y Growth Analysis, For Countries, 2017–2027
- North America
  - Introduction
  - Market Size and Forecast, By Treatment Type, 2016–2027 (US$ Mn)
  - Market Size and Forecast, By Enzyme Deficiency Type, 2016–2027 (US$ Mn)
  - Market Size and Forecast, By Route of Administration, 2016–2027 (US$ Mn)
  - Market Size and Forecast, By Distribution Channel, 2016–2027 (US$ Mn)
  - Market Size and Forecast, By Country, 2016–2027 (US$ Mn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, By Treatment Type, 2016–2027 (US$ Mn)
  - Market Size and Forecast, By Enzyme Deficiency Type, 2016–2027 (US$ Mn)
  - Market Size and Forecast, By Route of Administration, 2016–2027 (US$ Mn)
  - Market Size and Forecast, By Distribution Channel, 2016–2027 (US$ Mn)
  - Market Size and Forecast, By Country, 2016–2027 (US$ Mn)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, By Treatment Type, 2016–2027 (US$ Mn)
  - Market Size and Forecast, By Enzyme Deficiency Type, 2016–2027 (US$ Mn)
  - Market Size and Forecast, By Route of Administration, 2016–2027 (US$ Mn)
  - Market Size and Forecast, By Distribution Channel, 2016–2027 (US$ Mn)
  - Market Size and Forecast, By Country, 2016–2027 (US$ Mn)
    - Germany
    - U.K.
    - France
    - Italy
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, By Treatment Type, 2016–2027 (US$ Mn)
  - Market Size and Forecast, By Enzyme Deficiency Type, 2016–2027 (US$ Mn)
  - Market Size and Forecast, By Route of Administration, 2016–2027 (US$ Mn)
  - Market Size and Forecast, By Distribution Channel, 2016–2027 (US$ Mn)
  - Market Size and Forecast, By Country, 2016–2027 (US$ Mn)
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, By Treatment Type, 2016–2027 (US$ Mn)
  - Market Size and Forecast, By Enzyme Deficiency Type, 2016–2027 (US$ Mn)
  - Market Size and Forecast, By Route of Administration, 2016–2027 (US$ Mn)
  - Market Size and Forecast, By Distribution Channel, 2016–2027 (US$ Mn)
  - Market Size and Forecast, By Country, 2016–2027 (US$ Mn)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, By Treatment Type, 2016–2027 (US$ Mn)
  - Market Size and Forecast, By Enzyme Deficiency Type, 2016–2027 (US$ Mn)
  - Market Size and Forecast, By Route of Administration, 2016–2027 (US$ Mn)
  - Market Size and Forecast, By Distribution Channel, 2016–2027 (US$ Mn)
  - Market Size and Forecast, By Country/Region, 2016–2027 (US$ Mn)
    - South Africa
    - Central Africa
    - North Africa
Competitive Landscape
- Company Profiles
  - Bausch Health Companies, Inc.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Recordati Rare Diseases Inc.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Lucane Pharma SA
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Acer Therapeutics
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Ultragenyx Pharmaceutical Inc.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Aeglea BioTherapeutics
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Arcturus Therapeutics Holdings Inc.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Orpharma Pty Ltd.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Selecta Biosciences, Inc.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Abbott Laboratories
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - NESTLÉ S.A.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - DANONE S.A.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Mead Johnson & Company, LLC
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies

*Browse 72 market data tables and 48 figures on " Urea Cycle Disorders Treatment Market – Global forecast to 2027”.

Get Instant Access - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now